Showing results (71-80 of 112) with videos related to
Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2010
Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activationInes A Silva, Krystyna Olkiewicz, David Askew, et al.Stem Cells (Dayton, Ohio)|July 13, 2021
Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activityLeland Metheny, Saada Eid, Patiwet Wuttisarnwattana, et al.Pediatric Blood & Cancer|June 11, 2020
Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation: The PEDECOR experienceDiana A Steppan, Ryan D Coleman, Heather K Viamonte, et al.Blood Advances|September 18, 2025
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 yearsAnna C Ferreira, Debjani Dutta, Courtney M Rowan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2005
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host diseaseJoseph P Uberti, Lois Ayash, Voravit Ratanatharathorn, et al.Blood|July 21, 2007
CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantationSung W Choi, Gerhard C Hildebrandt, Krystyna M Olkiewicz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.Blood|October 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai, et al.Stem Cells (Dayton, Ohio)|October 23, 2014
Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantationJeffery J Auletta, Saada K Eid, Patiwet Wuttisarnwattana, et al.Haematologica|January 28, 2017
Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamideChristopher G Kanakry, Giorgos Bakoyannis, Susan M Perkins, et al.Pageof 12